Vincenzo Solfrizzi1, Emanuele Scafato2, Davide Seripa3, Madia Lozupone4, Bruno P Imbimbo5, Angela D'Amato1, Rosanna Tortelli4, Andrea Schilardi1, Lucia Galluzzo2, Claudia Gandin2, Marzia Baldereschi6, Antonio Di Carlo6, Domenico Inzitari7, Antonio Daniele8, Carlo Sabbà1, Giancarlo Logroscino9, Francesco Panza10. 1. Department of Geriatric Medicine, Memory Unit and Rare Disease Center, University of Bari Aldo Moro, Bari, Italy. 2. Population Health and Health Determinants Unit, National Center for Epidemiology, Surveillance and Health Promotion (CNESPS), Istituto Superiore di Sanità (ISS), Roma, Italy. 3. Gerontology-Geriatrics Research Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 4. Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy. 5. Research and Development Department, Chiesi Farmaceutici, Parma, Italy. 6. Institute of Neuroscience, Italian National Research Council (CNR), Firenze, Italy. 7. Institute of Neuroscience, Italian National Research Council (CNR), Firenze, Italy; Department of NEUROFARBA, Neuroscience Section, University of Florence, Florence, Italy. 8. Institute of Neurology, Catholic University of Sacred Heart, Rome, Italy. 9. Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy; Department of Clinical Research in Neurology, University of Bari Aldo Moro, Pia Fondazione Cardinale G. Panico, Tricase, Lecce, Italy. 10. Gerontology-Geriatrics Research Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy; Department of Clinical Research in Neurology, University of Bari Aldo Moro, Pia Fondazione Cardinale G. Panico, Tricase, Lecce, Italy. Electronic address: geriat.dot@geriatria.uniba.it.
Abstract
OBJECTIVES: Cognitive frailty, a condition describing the simultaneous presence of physical frailty and mild cognitive impairment, has been recently defined by an international consensus group. We estimated the predictive role of a "reversible" cognitive frailty model on incident dementia, its subtypes, and all-cause mortality in nondemented older individuals. We verified if vascular risk factors or depressive symptoms could modify this predictive role. DESIGN: Longitudinal population-based study with 3.5- and 7-year of median follow-up. SETTING: Eight Italian municipalities included in the Italian Longitudinal Study on Aging. PARTICIPANTS: In 2150 older individuals from the Italian Longitudinal Study on Aging, we operationalized reversible cognitive frailty with the presence of physical frailty and pre-mild cognitive impairment subjective cognitive decline, diagnosed with a self-report measure based on item 14 of the Geriatric Depression Scale. MEASUREMENTS: Incidence of dementia, its subtypes, and all-cause mortality. RESULTS: Over a 3.5-year follow-up, participants with reversible cognitive frailty showed an increased risk of overall dementia [hazard ratio (HR) 2.30, 95% confidence interval (CI) 1.02-5.18], particularly vascular dementia (VaD), and all-cause mortality (HR 1.74, 95% CI 1.07-2.83). Over a 7-year follow-up, participants with reversible cognitive frailty showed an increased risk of overall dementia (HR 2.12, 95% CI 1.12-4.03), particularly VaD, and all-cause mortality (HR 1.39, 95% CI 1.03-2.00). Vascular risk factors and depressive symptoms did not have any effect modifier on the relationship between reversible cognitive frailty and incident dementia and all-cause mortality. CONCLUSIONS: A model of reversible cognitive frailty was a short- and long-term predictor of all-cause mortality and overall dementia, particularly VaD. The absence of vascular risk factors and depressive symptoms did not modify the predictive role of reversible cognitive frailty on these outcomes.
OBJECTIVES: Cognitive frailty, a condition describing the simultaneous presence of physical frailty and mild cognitive impairment, has been recently defined by an international consensus group. We estimated the predictive role of a "reversible" cognitive frailty model on incident dementia, its subtypes, and all-cause mortality in nondemented older individuals. We verified if vascular risk factors or depressive symptoms could modify this predictive role. DESIGN: Longitudinal population-based study with 3.5- and 7-year of median follow-up. SETTING: Eight Italian municipalities included in the Italian Longitudinal Study on Aging. PARTICIPANTS: In 2150 older individuals from the Italian Longitudinal Study on Aging, we operationalized reversible cognitive frailty with the presence of physical frailty and pre-mild cognitive impairment subjective cognitive decline, diagnosed with a self-report measure based on item 14 of the Geriatric Depression Scale. MEASUREMENTS: Incidence of dementia, its subtypes, and all-cause mortality. RESULTS: Over a 3.5-year follow-up, participants with reversible cognitive frailty showed an increased risk of overall dementia [hazard ratio (HR) 2.30, 95% confidence interval (CI) 1.02-5.18], particularly vascular dementia (VaD), and all-cause mortality (HR 1.74, 95% CI 1.07-2.83). Over a 7-year follow-up, participants with reversible cognitive frailty showed an increased risk of overall dementia (HR 2.12, 95% CI 1.12-4.03), particularly VaD, and all-cause mortality (HR 1.39, 95% CI 1.03-2.00). Vascular risk factors and depressive symptoms did not have any effect modifier on the relationship between reversible cognitive frailty and incident dementia and all-cause mortality. CONCLUSIONS: A model of reversible cognitive frailty was a short- and long-term predictor of all-cause mortality and overall dementia, particularly VaD. The absence of vascular risk factors and depressive symptoms did not modify the predictive role of reversible cognitive frailty on these outcomes.
Authors: Brian Downer; Soham Al Snih; Bret T Howrey; Mukaila A Raji; Kyriakos S Markides; Kenneth J Ottenbacher Journal: Aging Ment Health Date: 2018-11-24 Impact factor: 3.658
Authors: Márlon J R Aliberti; Irena S Cenzer; Alexander K Smith; Sei J Lee; Kristine Yaffe; Kenneth E Covinsky Journal: J Am Geriatr Soc Date: 2018-11-23 Impact factor: 5.562
Authors: C Chen; J T Lim; N C Chia; L Wang; B Tysinger; J Zissimopolous; M Z Chong; Z Wang; G C Koh; J M Yuan; K B Tan; K S Chia; A R Cook; R Malhotra; A Chan; S Ma; T P Ng; W P Koh; D P Goldman; J Yoong Journal: J Econ Ageing Date: 2019-02-27
Authors: Elizabeth Mahanna-Gabrielli; Kathy Zhang; Frederick E Sieber; Hung Mo Lin; Xiaoyu Liu; Margaret Sewell; Stacie G Deiner; Kenneth S Boockvar Journal: Anesth Analg Date: 2020-06 Impact factor: 5.108
Authors: Lana Sargent; Mike Nalls; Angela Starkweather; Sarah Hobgood; Holly Thompson; Elaine J Amella; Andrew Singleton Journal: Ageing Res Rev Date: 2018-08-10 Impact factor: 10.895